Best Practices in Developing Proprietary Names for Human Prescription Drug Products; Guidance for Industry: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 8, 2020
December 9, 2020
884d34d7-a96d-446a-8c81-afb4c4e499ac
Related Documents
Referencing Approved Drug Products in ANDA Submissions Guidance for Industry
Guidance DocumentOctober 27, 2020Center for Drug Evaluation and Research
Contents of a Complete Submission for the Evaluation of Proprietary Names
Guidance DocumentApril 11, 2016Center for Drug Evaluation and Research
Homeopathic Drug Products Guidance for FDA Staff and Industry
Guidance DocumentDecember 7, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox